Cohance Lifesciences

Name	:	Cohance Lifesciences
Website	:	Visit Website
Blog	:	Visit Blog
Social Links	:

About Cohance Lifesciences

Cohance Lifesciences is not just a brand—it’s a culmination of vision, scientific ambition, and purposeful integration. Our story began with a series of intentional moves, starting with the acquisition of RA Chem Pharma. Over time, a deliberate series of mergers and acquisitions—including ZCL Chemicals, Avra Laboratories, Suven Pharmaceuticals, Sapala Organics, and NJ Bio—brought together differentiated capabilities in Pharma CDMO, APIs, Specialty Chemicals, Formulations, and next-gen platforms like ADCs and Oligonucleotides.

Trusted Pharmaceutical CDMO & CRDMO Partner for Innovative Drug Development

Cohance Lifesciences31 Aug, 2026Other

Looking for a reliable pharmaceutical CDMO or CRDMO partner? Cohance Lifesciences provides integrated drug development and manufacturing solutions across small molecule APIs, antibody-drug conjugates (ADCs), nucleic acid chemistry, generic APIs, and specialty chemicals. With expertise spanning research, process development, scale-up, and commercial manufacturing, Cohance supports pharmaceutical and biopharmaceutical companies with quality-focused and scalable solutions. Explore Cohance’s global capabilities and discover a trusted partner for advancing complex drug development programs.